Corporate Profile

Corporate Overview

Company name Taiko Pharmaceutical Co., Ltd.
Establishment date November 18, 1946
Capital JPY 10 million (as of the end of December 2024)
Scope of businesses
【Pharmaceutical business】
Manufacturing and sales of OTC medicines (SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet), and designated quasi-drugs (RAPPA INTESTINAL REGULATOR BF)

【Infection control business】
Manufacturing and sales of sanitation control products (including Cleverin and Cleverin Generator LISPASS)

【Other business】
Manufacturing and sales of wood vinegar-based products
Final accounting date December 31
Employees Consolidate base: 214 employees, Non-consolidated base: 186 employees(As of December 31, 2024)
Officers
Chairman Hitoshi Shibata
President and CEO Takashi Shibata
Headquarters
  • 1-4-1, Nishi-Honmachi, Nishi-ku, Osaka map
  • TEL : +81-6-4391-1110
Office
【Production bases】
  • ・Suita Plant (Osaka) map
  • ・Kyoto Plant/R&D Center (Kyoto) map
  • ・Oguni Plant (Yamagata) map
【Sales bases】
  • ・Tokyo Office (Tokyo) map
Affiliates
【Japan】
  • ・Taiko TEC Co., Ltd. (Yamagata) map
  • ・Taiko Pharmaceutical International Co., Ltd. (Osaka)
【Overseas】
  • ・Taiko Pharmaceutical (Asia Pacific) Co., Ltd (Hong Kong)
  • ・Taiko Environmental Technologies (Shanghai) Co., Ltd.
  • ・Taiwan Taiko Pharmaceutical Co., Ltd.
  • ・Taiko Pharmaceutical (Shenzhen) Co., Ltd.

Medical Products

Infection Control Products

Research and Development

Corporate Profile

Investor Information